Brii Biosciences Limited
BRIBF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $5 | $8 |
| - Cash | $1 | $0 | $1 | $3 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | $1 | $4 | $5 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 7,993.4% | -98.8% | -44.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$1 | -$1 |
| % Margin | -804.2% | -27,261.3% | -975.4% | -651.4% |
| Net Income | -$1 | -$0 | -$0 | -$4 |
| % Margin | -1,017.6% | -28,335.3% | -938.1% | -4,452.3% |
| EPS Diluted | -0.7 | -0.24 | -0.67 | -9.48 |
| % Growth | -191.7% | 64.2% | 92.9% | – |
| Operating Cash Flow | -$0 | -$1 | -$0 | -$1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$1 | -$1 | -$1 |